Enterprise Tech Ecosystem Series: Smith+Nephew - 2025
Description
Enterprise Tech Ecosystem Series: Smith+Nephew - 2025
Summary
Smith+Nephew is a UK-based medical technology company offering a wide range of medical devices to patients in more than 100 countries across the world. The company operates through three global business units: Orthopaedics, Sports Medicine & Ear, Nose and Throat (ENT) and Advanced Wound Management (AWM). The Orthopaedics business division offers hip and knee implants for replacing worn, damaged, or diseased joints; robotics-assisted and enabling technologies; and services for surgeons. This division also offers trauma products for stabilizing severe fractures and correcting bone deformities. Smith+Nephew’s Sports Medicine portfolio comprises implants, technology, and instruments that facilitate minimally invasive surgical procedures. The company’s ENT portfolio includes products for tonsil and adenoid removal, tympanostomy, sinus surgery, turbinate reduction, septoplasty, laryngeal and soft palate reduction, and epistaxis. Its AWM product portfolio includes products for treating chronic and acute wounds, such as diabetic and pressure ulcers, leg wounds, post-operative wounds, and burns.
The report provides information and insights into Smith+Nephew's tech activities, including -
Summary
Smith+Nephew is a UK-based medical technology company offering a wide range of medical devices to patients in more than 100 countries across the world. The company operates through three global business units: Orthopaedics, Sports Medicine & Ear, Nose and Throat (ENT) and Advanced Wound Management (AWM). The Orthopaedics business division offers hip and knee implants for replacing worn, damaged, or diseased joints; robotics-assisted and enabling technologies; and services for surgeons. This division also offers trauma products for stabilizing severe fractures and correcting bone deformities. Smith+Nephew’s Sports Medicine portfolio comprises implants, technology, and instruments that facilitate minimally invasive surgical procedures. The company’s ENT portfolio includes products for tonsil and adenoid removal, tympanostomy, sinus surgery, turbinate reduction, septoplasty, laryngeal and soft palate reduction, and epistaxis. Its AWM product portfolio includes products for treating chronic and acute wounds, such as diabetic and pressure ulcers, leg wounds, post-operative wounds, and burns.
The report provides information and insights into Smith+Nephew's tech activities, including -
- Insights of its digital transformation strategies and innovation programs.
- Overview of technology initiatives covering partnerships, product launches, investments and acquisitions.
- Insights on each technology initiative including technology theme, objective, and benefits.
- Details of estimated ICT budgets.
- The report provides insights into the company’s tech activities, including its digital transformation strategies, its innovation programs, its technology initiatives, its investments and its acquisitions.
- Gain insights into Smith+Nephew's tech operations.
- Gain insights into its tech strategies and innovation initiatives.
- Gain insights into its technology themes under focus.
- Gain insights into various product launches, partnerships, investments and acquisitions.
Table of Contents
25 Pages
- Smith+Nephew’s Overview
- Smith+Nephew’s Digital Transformation Strategy
- Smith+Nephew’s Accelerators, Incubators, and other Innovation Programs
- Smith+Nephew’s Technology Focus
- Smith+Nephew’s Technology Initiatives
- Smith+Nephew’s Tech Investments
- Smith+Nephew’s Tech Acquisitions
- Smith+Nephew’s Tech Ecosystem
- Smith+Nephew’s ICT Budget and Contracts
- Smith+Nephew’s Key Executives
- Smith+Nephew’s Thematic Scorecard
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
